Holly M. Akilesh

Holly M. Akilesh

Auto-generated profile, based on publicly available information

Holly M. Akilesh

Immunology Program, Benaroya Research Institute, Seattle, WA, USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 January 2019 in Science
Verified
Journal Article
Closed access
PDF file
HAHolly M. Akilesh
Holly M. Akilesh
MBMatthew B. Buechler
Matthew B. Buechler
JDJeffrey M. Duggan
Jeffrey M. Duggan
WHWilliam O. Hahn
William O. Hahn
BMBharati Matta
Bharati Matta
JHJessica A. Hamerman
Jessica A. Hamerman
Unmasking an agent of inflammatory anemia: Infectious and autoimmune diseases are associated with anemia and thrombocytopenia. A severe form of inflammatory cytopenia called macrophage activation syndrome (MAS) may occur during rheumatological disorders and viral infections. Akilesh et al. show that monocyte recognition of self- or pathogen-derived nucleic acids via Toll-like receptors 7 and 9 (TLR7 and TLR9) drives MAS-like disease in mice. TLR7 or TLR9 signaling in monocytes causes these cells to differentiate into inflammatory hematophagocytes (iHPCs), which are similar to but distinct from red pulp macrophages. Preventing iHPC differentiation by depleting monocytes relieves MAS-like symptoms. When mice were subjected to a model of malarial anemia, MyD88- and endosomal TLR-dependent iHPC differentiation also occurred. Thus, iHPCs may play a role in both MAS-driven and malarial anemia, as well as thrombocytopenia. Science , this issue p. eaao5213